Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023)
Titel:
Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023)
Auteur:
Iannantuono, Giovanni Maria Floudas, Charalampos S. Filetti, Marco Giovagnoli, Tommaso Sganga, Stefano Vitale, Antonio Chandran, Elias Lombardi, Pasquale Rosenfeld, Roberto Giudice, Elena Xue, Elisabetta Rapisarda, Elvira Troisi, Paola Apolo, Andrea B. Karzai, Fatima Bria, Emilio Gulley, James L. Daniele, Gennaro